+1,057.4%
MRNA vs THC
+1,118.8%
-61.4%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.6% | +1.9% | -5.6% | -3.8% |
| 7D | -20.0% | +0.9% | -20.9% | -20.0% |
| 30D | -1.3% | +9.1% | -10.3% | -2.0% |
| 3M | +240.0% | +8.8% | +231.1% | +237.1% |
| 6M | +339.0% | +48.2% | +290.7% | +321.5% |
| YTD | +630.0% | +46.7% | +583.3% | +599.2% |
| 1Y | +769.1% | +51.1% | +717.9% | +729.6% |
| 3Y | +181.2% | +401.4% | -220.2% | +140.2% |
| 5Y | -8.1% | +265.8% | -273.9% | -21.2% |
| All | +1,057.4% | +1,118.8% | -61.4% | +832.8% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling